Xtant Medical Holdings noncompliant with NYSE continued listing requirements — 3 insights

Spinal Tech

NYSE American informed orthopedic and spinal device company Xtant Medical Holdings it was noncompliant with certain aspects of the stock exchange's continued listing requirements.

What you should know:

1. Xtant is not in compliance with three different sections of the NYSE's American Company Guide because Xtant posted negative stockholder equity of $43.77 million as of Dec. 31, 2018, and had net losses in five of its most recent fiscal years.

2. Xtant must deliver a plan of compliance to NYSE American by May 4. Xtant must be compliant again by Oct. 4, 2020.

3. Xtant will continue to trade on the NYSE but will have the ".BC" designation added to its symbol to denote its noncompliant status.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers